Attendees represented a diverse mix of first-time participants and seasoned Institute veterans, creating an environment rich in curiosity, experience, and shared learning. From the first session to the final hands-on demonstration, the energy remained high, driven by one common goal: translating regenerative technologies into better, more predictable patient outcomes.
This was not a conference built solely on theory. It was designed to challenge assumptions, refine protocols, and equip clinicians with actionable insights they could implement immediately in practice.
Unlike traditional Shockwave Therapy educational events that focus heavily on device specifications or isolated parameters, the Boston conference centered on clinical reasoning and protocol-driven application.
Throughout the program, the emphasis remained on:
Sessions consistently reinforced that Shockwave therapy training is most effective when it extends beyond “how to use the device” and addresses the clinical decision-making underlying each treatment choice. Presentations were structured around real cases, tangible outcomes, and real challenges clinicians face daily in practice.
Equally important was the level of audience engagement. Questions were encouraged, discussions were candid, and presenters welcomed dialogue. This created an environment where learning felt intentionally collaborative.
These perspectives underscore the importance of evidence-based decision-making, hands-on experience, and ongoing education in advancing patient outcomes.
Prof. Dr. Karsten Knobloch (Germany) presented real-world clinical cases demonstrating how combined Shockwave and EMTT protocols drive meaningful functional improvements and faster return-to-activity across musculoskeletal and sports-related conditions. His presentation delivered practical, evidence-informed protocol insights that clinicians can implement immediately, emphasizing precision, sequencing, and biologically driven treatment decisions.
Paul Hobrough (UK) shared clinical cases illustrating how optimized Shockwave and EMTT protocols accelerate functional recovery and shorten return-to-activity timelines across athletic and musculoskeletal populations. His presentation delivered clear, practical protocol insights clinicians can use in practice, with an emphasis on targeted treatment, dosing strategies, and clinical reasoning over device settings alone.
Michael Chin, DPM, presented cases demonstrating how a CBG/CBD transdermal topical can be
Brian Nathanson, DC, focused on complex breast cancer–related case studies, demonstrating how Shockwave and EMTT can be applied to address post-mastectomy pain, fascial restriction, and shoulder dysfunction. His impairment-based approach highlighted measurable functional improvements, return-to-activity outcomes, and practical, patient-specific protocol insights clinicians can implement when treating beyond the site of pain.
Keith Roed, DPT, shared compelling early results from a multi-year case series using Shockwave and EMTT to treat patients with multiple sclerosis and motor neuron disease. His protocol demonstrated significant, measurable improvements in gait, balance, strength, and quality of life, suggesting a potential paradigm shift in neurologic care.
A defining feature of the Institute Conference was the emphasis on hands-on experience. Live demonstrations took place both on stage and on screen, allowing attendees to observe technique, positioning, and treatment flow in real time.
Guided sessions gave clinicians the opportunity to:
For many attendees, this hands-on exposure was the difference between conceptual understanding and actual clinical preparedness. Observing protocols applied in practice and understanding the rationale behind each step shortens the learning curve and reinforces best practices.
The result was a training experience that moved beyond observation and into application, a hallmark of effective EMTT and Shockwave therapy education which is always a highlight of the Institute Conference series and sets this event apart from others offered.
The expert panel discussion at the end of the first day was another highlight of the conference. These sessions sparked thoughtful dialogue and encouraged clinicians to engage openly about both successes and challenges. Panelists included: Dr. Rob Conenello, Dr. Aneesh Garg, Paul Hobrough, Dr. Veronica Jow, and Dr. Paul Tortland, and topics ranged from:
Audience participation was lively, with insightful questions driving meaningful exchanges. Rather than scripted discussions, panels evolved organically, shaped by real-world concerns raised by attendees.
This peer-to-peer learning model reinforced the value of shared experience and underscored why Institute events continue to resonate so powerfully with clinicians across specialties.
Sunday’s sessions shifted focus toward the business side of regenerative medicine, an area of increasing importance as EMTT and Shockwave gain wider adoption in medical practices.
Presenters shared expertise and success stories about practice marketing to attract more patients. Here are some highlights from the presenters.
These conversations are critical: delivering high-quality care also requires strategic practice management. Attendees left with practical insights on educating patients, differentiating their services, and building practices that support long-term growth without compromising clinical integrity.
Key Clinical and Practice Insights
In medicine, peer validation carries exceptional weight. Insights are most meaningful when they come from clinicians who have applied new technologies and education in real-world practice.
The following reflections from attendees of this recent Institute Conference highlight the clinical value, practical insight, and professional impact of this EMTT and Shockwave therapy training experience.
Cheri Chan, DPT
Health Fit Inc.
Michael J Chin, DPM
The Running Institute
Marc Lederman, DPM
West Hartford Podiatry Associates
Andi Renshaw, PT
Renew Physical Therapy & Pilates
Dr. Keith Roed, DPT
Impact Physical Therapy
Momentum continues to build for the Institute for Tissue Regeneration & Repair. Two conferences are planned for 2026 to include May 16-17 in Phoenix, and December 5-6 in Boston.
Watch this video to get a glimpse of highlights from the event.
As regenerative medicine evolves, so does the need for structured, evidence-based education. Institute conferences remain a cornerstone for clinicians seeking not only to stay current but to lead with confidence, precision, and purpose.
For those committed to advancing patient care through EMTT and Shockwave therapy training, this conference served as a clear reminder. When education is done right, it can transform medical practices and improve patient care.
This event was made possible through the generous support of our sponsors:
Exo Advantage, Marlinz Pharma, and New Lane Finance.
CuraMedix is passionate about providing meaningful educational opportunities for clinicians, equipping them with the tools and clinical insights they need to advance care and outcomes.
Contact us today to speak with a device expert who understands your goals.